...
首页> 外文期刊>Archives of Orthopaedic and Trauma Surgery >Recombinant bone morphogenic protein-2 in orthopaedic surgery: a review
【24h】

Recombinant bone morphogenic protein-2 in orthopaedic surgery: a review

机译:骨整形手术中重组骨形态发生蛋白2的研究进展

获取原文
获取原文并翻译 | 示例
           

摘要

Bone morphogenic proteins (BMPs) are pleiotropic regulators of bone volume, skeletal organogenesis and bone regeneration after a fracture. They function as signaling agents to affect cellular events like proliferation, differentiation and extracellular matrix synthesis. Clinically utilized rhBMP-2 combines rhBMP-2 with an osteoconductive carrier to induce bone growth and acts as a bone graft substitute. rhBMP-2, initially released in 2002, has been used primarily in spinal fusions in the lumbar and cervical regions. Recently, the application of rhBMP-2 has extended into the orthopedic trauma setting with increased application in open tibia fractures. This review outlines the history of development, molecular characteristics, toxicity and clinical applications.
机译:骨形态发生蛋白(BMP)是骨折后骨骼体积,骨骼器官生成和骨骼再生的多效性调节剂。它们作为信号传导剂来影响细胞事件,如增殖,分化和细胞外基质合成。临床上使用的rhBMP-2将rhBMP-2与骨传导性载体结合在一起,以诱导骨骼生长并充当骨移植替代物。 rhBMP-2最初于2002年发布,主要用于腰椎和颈椎区域的脊柱融合术。最近,随着在开放性胫骨骨折中的应用增加,rhBMP-2的应用已扩展到整形外科创伤领域。这篇综述概述了发展历史,分子特征,毒性和临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号